Wellington Management Group
DNTH icon

Wellington Management Group’s Dianthus Therapeutics DNTH Stock Holding History

Wellington Management Group’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315M Buy
3,229,882
+634,099
+24% +$55.4M 0.05% 297
2026
Q1 		$218M Buy
2,595,783
+92,593
+4% +$5.36M 0.04% 363
2025
Q4 		$103M Sell
2,503,190
-74,472
-3% -$2.89M 0.02% 543
2025
Q3 		$101M Buy
2,577,662
+2,503,311
+3,367% +$64M 0.02% 552
2025
Q2 		$1.39M Buy
74,351
+6,369
+9% +$119K ﹤0.01% 1662
2025
Q1 		$1.23M Buy
67,982
+7,645
+13% +$168K ﹤0.01% 1660
2024
Q4 		$1.32M Buy
60,337
+6,552
+12% +$168K ﹤0.01% 1668
2024
Q3 		$1.47M Buy
+53,785
New +$1.5M ﹤0.01% 1632
2022
Q4 		– Sell
-80,389
Closed -$1.81M – 2021
2022
Q3 		$1.81M Sell
80,389
-571
-0.7% -$15.6K ﹤0.01% 1545
2022
Q2 		$1.55M Sell
80,960
-616
-0.8% -$15.2K ﹤0.01% 1591
2022
Q1 		$3.79M Buy
+81,576
New +$4.46M ﹤0.01% 1456

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Wellington Management Group's DNTH Position: Q2 2026 in Review

Wellington Management Group increased its Dianthus Therapeutics (DNTH) stake by 24% in Q2 2026, buying an estimated $55.4M and bringing the position to 3,229,882 shares worth $315M. The position accounts for 0.05% of the portfolio, ranked #297.

Wellington Management Group first reported a position in DNTH in Q1 2022 and has held it in 11 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Wellington Management Group held 3,229,882 shares of Dianthus Therapeutics worth $315M as of Q2 2026.
  • Wellington Management Group bought 634,099 Dianthus Therapeutics shares in Q2 2026, an estimated $55.4M.
  • Dianthus Therapeutics made up 0.05% of Wellington Management Group's portfolio in Q2 2026, its #297 holding.
  • Wellington Management Group first reported a position in Dianthus Therapeutics in Q1 2022 and has held it in 11 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.